Motion Reset for Cybersickness in Virtual Reality
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new software called Motion Reset to determine if it can reduce cybersickness symptoms such as eye strain, nausea, dizziness, or headaches during virtual reality (VR) use. Researchers will divide participants into three groups to experience different VR settings and identify which setting provides the most relief. Healthy adults who have experienced some level of motion sickness and do not have conditions that increase nausea susceptibility are ideal candidates for this study. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance VR experiences for many.
Will I have to stop taking my current medications?
If you are currently using medications or supplements that prevent nausea, like Zofran or Phenergan, you cannot participate in this trial.
What prior data suggests that the Motion Reset software is safe for reducing cybersickness in VR users?
Research has shown that specific safety information for the Motion Reset software is not available. However, virtual reality (VR) can sometimes cause mild and temporary symptoms such as nausea or dizziness. In one study, about 45% of VR users experienced these symptoms during use, and 25% continued to feel them an hour later. Although this study does not specifically cover Motion Reset, it provides insight into what VR users might generally experience.12345
Why are researchers excited about this trial?
Researchers are excited about the Motion Reset protocol for cybersickness in virtual reality because it aims to tackle the problem directly by adjusting the user's sensory input in real-time. Unlike other methods that rely on medications or gradual exposure to reduce symptoms, Motion Reset is designed to recalibrate the user’s experience instantly, potentially offering immediate relief. This innovative approach could revolutionize how we manage cybersickness, making virtual reality more accessible and enjoyable for everyone.
What evidence suggests that Motion Reset is effective for reducing cybersickness?
Research has shown that software like Motion Reset, which participants in this trial may experience, can help reduce cybersickness, a condition similar to motion sickness. Adding a virtual nose to VR displays has been shown to reduce motion sickness symptoms. Another method, called teleportation, can also help but might make it harder to orient oneself in the virtual world. Some studies indicate that VR can cause discomfort, such as nausea and dizziness, but innovations like Motion Reset aim to address these issues. While specific data on Motion Reset is still being gathered, these strategies offer promising ways to reduce cybersickness during VR use.16789
Who Is on the Research Team?
Susan J Persky, Ph.D.
Principal Investigator
National Human Genome Research Institute (NHGRI)
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18 to 60 who are interested in participating in a study involving virtual reality (VR). The goal is to see if new software can help prevent the discomfort some people feel after using VR, known as cybersickness.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are assigned to one of three groups to experience VR activities designed to prevent or not prevent cybersickness, or no VR experience.
VR Game Session
All participants play a commercial VR game and are monitored for cybersickness symptoms.
Follow-up
Participants complete questionnaires about their VR experience and symptoms.
What Are the Treatments Tested in This Trial?
Interventions
- Motion Reset
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Human Genome Research Institute (NHGRI)
Lead Sponsor